Observational Study of Allergic Rhinitis in Children
NCT05655858 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 1004
Last updated 2025-10-03
Summary
Observational, cross-sectional, prospective, multicentric study in France with private paediatricians to describe the management of allergic rhinitis in children.
Conditions
- Allergic Rhinitis
Interventions
- OTHER
-
Management of allergic rhinitis
Collection of patient data in real-life
Sponsors & Collaborators
-
ALK-Abelló A/S
lead INDUSTRY
Eligibility
- Min Age
- 2 Years
- Max Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2022-11-23
- Primary Completion
- 2024-03-03
- Completion
- 2024-03-03
Countries
- France
Study Locations
More Related Trials
-
Perennial Allergic Rhinitis In Pediatric Subjects
NCT00257595 ·Status: COMPLETED ·Phase: PHASE3
-
Concomitant Intranasal Antihistamine and Corticosteroid in Stepwise Treatment Strategy for Allergic Rhinitis
NCT05708157 ·Status: UNKNOWN
-
Perennial Allergic Rhinitis Study In Pediatric Subjects
NCT00108914 ·Status: COMPLETED ·Phase: PHASE3
-
Validation of an Allergic Rhinitis Control Test in Teenagers
NCT02818153 ·Status: UNKNOWN ·Phase: NA
-
Study Of Perennial Allergic Rhinitis
NCT00358475 ·Status: COMPLETED ·Phase: PHASE3
-
Tolerability of ALK Grass Tablet in Children
NCT00310453 ·Status: COMPLETED ·Phase: PHASE1
-
Open Study to Evaluate the Safety of Levocetirizine in Young Children (2 - 6 Years) Suffering From Allergic Rhinitis
NCT00152412 ·Status: COMPLETED ·Phase: PHASE2
-
Montelukast in Mild Asthmatic Children With Allergic Rhinitis (0476-367)
NCT00442559 ·Status: COMPLETED ·Phase: PHASE4
-
Study In Adults And Adolescents With Seasonal Allergic Rhinitis.
NCT00225823 ·Status: COMPLETED ·Phase: PHASE3
-
Safety and Efficacy of Olopatadine HCl Nasal Spray in 6-11 Year Old Patients
NCT00578929 ·Status: COMPLETED ·Phase: PHASE3
-
Evaluation of Safety of Levocetirizine in Routine Clinical Practice-non- Interventional Study
NCT00598780 ·Status: COMPLETED
-
An Open Trial to Assess the Tolerability of AVANZ® Salsola Immunotherapy
NCT02065856 ·Status: COMPLETED ·Phase: PHASE2
-
Safety Study of Olopatadine Nasal Spray
NCT00578331 ·Status: COMPLETED ·Phase: PHASE3
-
The Development of Allergic Rhinitis in Children Previously Diagnosed as Nonallergic Rhinitis
NCT01068808 ·Status: COMPLETED
-
A Study Comparing Montelukast With Placebo in Children With Seasonal Allergic Rhinitis (0476-219)(COMPLETED)
NCT00968149 ·Status: COMPLETED ·Phase: PHASE3
-
Sensitivity and Specificity of Nasal Provocation Test in Allergic Rhinitis to House Dust Mites
NCT01485523 ·Status: COMPLETED
-
International Registry on the Quality of Life of Patients With Grass-pollen-induced Allergic Rhinitis
NCT02041624 ·Status: TERMINATED
-
Impact of AIT on Allergic Rhinitis and Asthma
NCT04125888 ·Status: COMPLETED
-
Combination Study Of S-555739/Cetirizine HCl In Adult Patients With Seasonal Allergic Rhinitis
NCT01651871 ·Status: COMPLETED ·Phase: PHASE2
-
Effectiveness of Montelukast Versus Intranasal Fluticasone Propionate in the Management of Allergic Rhinitis Among Children 02 to 05 Years of Age
NCT04957927 ·Status: UNKNOWN ·Phase: PHASE4
-
A Survey of Adults and Children With Allergic Rhinoconjunctivitis (MK-7243-021)
NCT01535118 ·Status: COMPLETED
-
Study on Association Between Treatment of Allergic Rhinitis and Cognitive Ability in Children
NCT03714945 ·Status: UNKNOWN
-
The Role of the Nasal Allergen Provocation Test in Starting and Monitoring Allergen Immunotherapy
NCT04544774 ·Status: RECRUITING
-
Impact Of Montelukast On Allergic Rhinitis And Its Inflammatory Makers
NCT05381207 ·Status: UNKNOWN ·Phase: EARLY_PHASE1
-
Evaluation of Treatment Satisfaction in Children With an Allergy and Who Received an Antihistamine
NCT00453583 ·Status: COMPLETED